Roles for SH2 and SH3 domains in Lyn kinase association with activated FcεRI in RBL mast cells revealed by patterned surface analysis

Journal of Structural Biology

Volumn 168, Issue 1, 2009, Pages 161-167

  Hammond, Stephanie ^a   Wagenknecht Wiesner, Alice ^a   Veatch, Sarah L ^a   Holowka, David ^a   Baird, Barbara ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Cross correlation analysis; IgE receptors

Indexed keywords

ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN E RECEPTOR; PROTEIN KINASE LYN; PROTEIN SH2; PROTEIN SH3;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; FLUORESCENCE; IMAGE ANALYSIS; MAST CELL; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; MAST CELLS; MICE; POINT MUTATION; PROTEIN BINDING; RECEPTORS, IGE; SRC HOMOLOGY DOMAINS; SRC-FAMILY KINASES;

EID: 69249222576     PISSN: 10478477     EISSN: 10958657     Source Type: Journal    
DOI: 10.1016/j.jsb.2009.04.012     Document Type: Article

References (57)

1. Abrams C.S., and Zhao W. SH3 domains specifically regulate kinase activity of expressed Src family proteins. J. Biol. Chem. 270 (1995) 333-339
2. Bauer F., Schweimer K., Meiselbach H., Hoffmann S., Rosch P., and Sticht H. Structural characterization of Lyn-SH3 domain in complex with a herpesviral protein reveals an extended recognition motif that enhances binding affinity. Protein Sci. 14 (2005) 2487-2498
3. Beaven M.A., and Metzger H. Signal transduction by Fc receptors: the FcεRI case. Immunol. Today 14 (1993) 222-226
4. Boggon T.J., and Eck M.J. Structure and regulation of Src family kinases. Oncogene 23 (2004) 7918-7927
5. Campbell R.E., Tour O., Palmer A.E., Steinbach P.A., Baird G.S., Zacharias D.A., and Tsien R.Y. A monomeric red fluorescent protein. PNAS 99 (2002) 7877-7882
6. Das R., Hammond S., Holowka D., and Baird B. Real-time cross-correlation image analysis of early events in IgE receptor signaling. Biophys. J. 94 (2008) 4996-5008
7. Dykstra M., Cherukuri A., Sohn H.W., Tzeng S.J., and Pierce S.K. Location is everything: lipid rafts and immune cell signaling. Annu. Rev. Immunol. 21 (2003) 457-481
8. Erpel T., Superti-Furga G., and Courtneidge S.A. Mutational analysis of the Src SH3 domain: the same residues of the ligand binding surface are important for intra- and intermolecular interactions. EMBO J. 14 (1995) 963-975
9. Field K.A., Holowka D., and Baird B. Compartmentalized activation of the high affinity immunoglobulin E receptor within membrane domains. J. Biol. Chem. 272 (1997) 4276-4280
10. Galli S.J., Nakae S., and Tsai M. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6 (2005) 135-142
11. Gilfillan A.M., and Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat. Rev. Immunol. 6 (2006) 218-230
12. Gosse J.A., Wagenknecht-Wiesner A., Holowka D., and Baird B. Transmembrane sequences are determinants of immunoreceptor signaling. J. Immunol. 175 (2005) 2123-2131
13. Gould H.J., Sutton B.J., Beavil A.J., Beavil R.L., McCloskey N., Coker H.A., Fear D., and Smurthwaite L. The biology of IgE and the basis of allergic disease. Annu. Rev. Immunol. 21 (2003) 579-628
14. Hess S.T., Sheets E.D., Wagenknecht-Wiesner A., and Heikal A.A. Quantitative analysis of the fluorescence properties of intrinsically fluorescent proteins in living cells. Biophys. J. 85 (2003) 2566-2580
15. Holowka D., Sheets E.D., and Baird B. Interactions between FcεRI and lipid raft components are regulated by the actin cytoskeleton. J. Cell Sci. 113 (2000) 1009-1019
16. Holowka D., Gosse J.A., Hammond A.T., Han X., Sengupta P., Smith N.L., Wagenknecht-Wiesner A., Wu M., Young R.M., and Baird B. Lipid segregation and IgE receptor signaling: a decade of progress. Biochim. Biophys. Acta 1746 (2005) 252-259
17. Honda Z., Suzuki T., Kono H., Okada M., Yamamoto T., Ra C., Morita Y., and Yamamoto K. Sequential requirements of the N-terminal palmitoylation site and SH2 domain of Src family kinases in the initiation and progression of FcεRI signaling. Mol. Cell. Biol. 20 (2000) 1759-1771
18. Ilic B., and Craighead H.G. Topographical patterning of chemically sensitive biological materials using a polymer-based dry lift off. Biomed. Microdevices 2 (2000) 317-322
19. Ingley E. Src family kinases: regulation of their activities, levels and identification of new pathways. Biochim. Biophys. Acta 1784 (2008) 56-65
20. Jouvin M.H., Adamczewski M., Numerof R., Letourneur O., Valle A., and Kinet J.P. Differential control of the tyrosine kinases Lyn and Syk by the two signaling chains of the high affinity immunoglobulin E receptor. J. Biol. Chem. 269 (1994) 5918-5925
21. Kihara H., and Siraganian R.P. Src homology 2 domains of Syk and Lyn bind to tyrosine-phosphorylated subunits of the high affinity IgE receptor. J. Biol. Chem. 269 (1994) 22427-22432
22. Koegl M., Zlatkine P., Ley S.C., Courtneidge S.A., and Magee A.I. Palmitoylation of multiple Src-family kinases at a homologous N-terminal motif. Biochem. J. 303 (1994) 749-753
23. Kuga T., Hoshino M., Nakayama Y., Kasahara K., Ikeda K., Obata Y., Takahashi A., Higashiyama Y., Fukumoto Y., and Yamaguchi N. Role of Src-family kinases in formation of the cortical actin cap at the dorsal cell surface. Exp. Cell Res. 314 (2008) 2040-2054
24. Larson D.R., Gosse J.A., Holowka D.A., Baird B.A., and Webb W.W. Temporally resolved interactions between antigen-stimulated IgE receptors and Lyn kinase on living cells. J. Cell Biol. 171 (2005) 527-536
25. Liang X., Nazarian A., Erdjument-Bromage H., Bornmann W., Tempst P., and Resh M.D. Heterogeneous fatty acylation of Src family kinases with polyunsaturated fatty acids regulates raft localization and signal transduction. J. Biol. Chem. 276 (2001) 30987-30994
26. Malek S.N., and Desiderio S. SH2 domains of the protein-tyrosine kinases Blk, Lyn, and Fyn(T) bind distinct sets of phosphoproteins from B lymphocytes. J. Biol. Chem. 268 (1993) 22557-22565
27. Marshall J.S. Mast-cell responses to pathogens. Nat. Rev. Immunol. 4 (2004) 779-787
28. Metcalfe D.D., Baram D., and Mekori Y.A. Mast cells. Physiol. Rev. 77 (1997) 1033-1079
29. Minoguchi K., Kihara H., Nishikata H., Hamawy M.M., and Siraganian R.P. Src family tyrosine kinase Lyn binds several proteins including paxillin in rat basophilic leukemia cells. Mol. Immunol. 31 (1994) 519-529
30. Odom S., Gomez G., Kovarova M., Furumoto Y., Ryan J.J., Wright H.V., Gonzalez-Espinosa C., Hibbs M.L., Harder K.W., and Rivera J. Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J. Exp. Med. 199 (2004) 1491-1502
31. Orth R.N., Wu M., Holowka D.A., Craighead H.G., and Baird B.A. Mast cell activation on patterned lipid bilayers of subcellular dimensions. Langmuir 19 (2003) 1599-1605
32. Panchamoorthy G., Fukazawa T., Stolz L., Payne G., Reedquist K., Shoelson S., Songyang Z., Cantley L., Walsh C., and Band H. Physical and functional interactions between SH2 and SH3 domains of the Src family protein tyrosine kinase p59fyn. Mol. Cell. Biol. 14 (1994) 6372-6385
33. Posner R.G., Lee B., Conrad D.H., Holowka D., Baird B., and Goldstein B. Aggregation of IgE-receptor complexes on rat basophilic leukemia cells does not change the intrinsic affinity but can alter the kinetics of the ligand-IgE interaction. Biochemistry 31 (1992) 5350-5356
34. Rathore V.B., Okada M., Newman P.J., and Newman D.K. Paxillin family members function as Csk-binding proteins that regulate Lyn activity in human and murine platelets. Biochem. J. 403 (2007) 275-281
35. Resh M.D. Regulation of cellular signalling by fatty acid acylation and prenylation of signal transduction proteins. Cell Signal. 8 (1996) 403-412
36. Reth M., and Brummer T. Feedback regulation of lymphocyte signalling. Nat. Rev. Immunol. 4 (2004) 269-277
37. Rickles R.J., Botfield M.C., Weng Z., Taylor J.A., Green O.M., Brugge J.S., and Zoller M.J. Identification of Src, Fyn, Lyn, PI3K and Abl SH3 domain ligands using phage display libraries. EMBO J. 13 (1994) 5598-5604
38. Sada K., Zhang J., and Siraganian R.P. SH2 domain-mediated targeting, but not localization, of Syk in the plasma membrane is critical for FcεRI signaling. Blood 97 (2001) 1352-1359
39. Saitoh S., Odom S., Gomez G., Sommers C.L., Young H.A., Rivera J., and Samelson L.E. The four distal tyrosines are required for LAT-dependent signaling in FcεRI-mediated mast cell activation. J. Exp. Med. 198 (2003) 831-843
40. Sheets E.D., Holowka D., and Baird B. Critical role for cholesterol in Lyn-mediated tyrosine phosphorylation of FcεRI and their association with detergent-resistant membranes. J. Cell Biol. 145 (1999) 877-887
41. Shiue L., Green J., Green O.M., Karas J.L., Morgenstern J.P., Ram M.K., Taylor M.K., Zoller M.J., Zydowsky L.D., Bolen J.B., et al. Interaction of p72syk with the gamma and beta subunits of the high-affinity receptor for immunoglobulin E, FcεRI. Mol. Cell. Biol. 15 (1995) 272-281
42. Shvartsman D.E., Donaldson J.C., Diaz B., Gutman O., Martin G.S., and Henis Y.I. Src kinase activity and SH2 domain regulate the dynamics of Src association with lipid and protein targets. J. Cell Biol. 178 (2007) 675-686
43. Stauffer T.P., Martenson C.H., Rider J.E., Kay B.K., and Meyer T. Inhibition of Lyn function in mast cell activation by SH3 domain binding peptides. Biochemistry 36 (1997) 9388-9394
44. Subramanian K., Holowka D., Baird B., and Goldstein B. The Fc segment of IgE influences the kinetics of dissociation of a symmetrical bivalent ligand from cyclic dimeric complexes. Biochemistry 35 (1996) 5518-5527
45. Superti-Furga G., Fumagalli S., Koegl M., Courtneidge S.A., and Draetta G. Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src. EMBO J. 12 (1993) 2625-2634
46. Torres A.J., Wu M., Holowka D., and Baird B. Nanobiotechnology and cell biology: micro- and nanofabricated surfaces to investigate receptor-mediated signaling. Annu. Rev. Biophys. 37 (2008) 265-288
47. Torres A.J., Vasudevan L., Holowka D., and Baird B.A. Focal adhesion proteins connect IgE receptors to the cytoskeleton as revealed by micropatterned ligand arrays. PNAS 105 (2008) 17238-17244
48. Turner H., and Kinet J.P. Signalling through the high-affinity IgE receptor FcεRI. Nature 402 (1999) B24-B30
49. Waksman G., Shoelson S.E., Pant N., Cowburn D., and Kuriyan J. Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms. Cell 72 (1993) 779-790
50. Weisstein, E.W. Wiener-Khinchin Theorem. From MathWorld-A Wolfram Web Resource. Available from: .
51. Wilson B.S., Pfeiffer J.R., and Oliver J.M. Observing FcεRI signaling from the inside of the mast cell membrane. J. Cell Biol. 149 (2000) 1131-1142
52. Wolven A., Okamura H., Rosenblatt Y., and Resh M.D. Palmitoylation of p59fyn is reversible and sufficient for plasma membrane association. Mol. Biol. Cell 8 (1997) 1159-1173
53. Wu M., Holowka D., Craighead H.G., and Baird B. Visualization of plasma membrane compartmentalization with patterned lipid bilayers. PNAS 101 (2004) 13798-13803
54. Wu M., Baumgart T., Hammond S., Holowka D., and Baird B. Differential targeting of secretory lysosomes and recycling endosomes in mast cells revealed by patterned antigen arrays. J. Cell Sci. 120 (2007) 3147-3154
55. Xu W., Doshi A., Lei M., Eck M.J., and Harrison S.C. Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol. Cell 3 (1999) 629-638
56. Young R.M., Zheng X., Holowka D., and Baird B. Reconstitution of regulated phosphorylation of FcεRI by a lipid raft-excluded protein-tyrosine phosphatase. J. Biol. Chem. 280 (2005) 1230-1235
57. Yu H., Chen J.K., Feng S., Dalgarno D.C., Brauer A.W., and Schreiber S.L. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76 (1994) 933-945